BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29750979)

  • 1. Ketamine facilitates extinction of avoidance behavior and enhances synaptic plasticity in a rat model of anxiety vulnerability: Implications for the pathophysiology and treatment of anxiety disorders.
    Fortress AM; Smith IM; Pang KCH
    Neuropharmacology; 2018 Jul; 137():372-381. PubMed ID: 29750979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysfunction in amygdala-prefrontal plasticity and extinction-resistant avoidance: A model for anxiety disorder vulnerability.
    Fragale JE; Khariv V; Gregor DM; Smith IM; Jiao X; Elkabes S; Servatius RJ; Pang KC; Beck KD
    Exp Neurol; 2016 Jan; 275 Pt 1(Pt 1):59-68. PubMed ID: 26546833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketamine and its metabolite, (2R,6R)-HNK, restore hippocampal LTP and long-term spatial memory in the Wistar-Kyoto rat model of depression.
    Aleksandrova LR; Wang YT; Phillips AG
    Mol Brain; 2020 Jun; 13(1):92. PubMed ID: 32546197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the hippocampus in avoidance learning and anxiety vulnerability.
    Cominski TP; Jiao X; Catuzzi JE; Stewart AL; Pang KC
    Front Behav Neurosci; 2014; 8():273. PubMed ID: 25152721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Danger and safety signals independently influence persistent pathological avoidance in anxiety-vulnerable Wistar Kyoto rats: A role for impaired configural learning in anxiety vulnerability.
    Spiegler KM; Smith IM; Pang KCH
    Behav Brain Res; 2019 Jan; 356():78-88. PubMed ID: 30063948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vulnerability factors in anxiety: Strain and sex differences in the use of signals associated with non-threat during the acquisition and extinction of active-avoidance behavior.
    Beck KD; Jiao X; Ricart TM; Myers CE; Minor TR; Pang KC; Servatius RJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1659-70. PubMed ID: 21601608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Avoidance perseveration during extinction training in Wistar-Kyoto rats: an interaction of innate vulnerability and stressor intensity.
    Jiao X; Pang KC; Beck KD; Minor TR; Servatius RJ
    Behav Brain Res; 2011 Aug; 221(1):98-107. PubMed ID: 21376086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paired-housing selectively facilitates within-session extinction of avoidance behavior, and increases c-Fos expression in the medial prefrontal cortex, in anxiety vulnerable Wistar-Kyoto rats.
    Smith IM; Pang KC; Servatius RJ; Jiao X; Beck KD
    Physiol Behav; 2016 Oct; 164(Pt A):198-206. PubMed ID: 27235339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketamine reverses the impaired fear memory extinction and accompanied depressive-like behaviors in adolescent mice.
    Wei MD; Wang YH; Lu K; Lv BJ; Wang Y; Chen WY
    Behav Brain Res; 2020 Feb; 379():112342. PubMed ID: 31705920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential use of danger and safety signals in an animal model of anxiety vulnerability: The behavioral economics of avoidance.
    Spiegler KM; Fortress AM; Pang KCH
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Mar; 82():195-204. PubMed ID: 29175308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vulnerability factors in anxiety determined through differences in active-avoidance behavior.
    Beck KD; Jiao X; Pang KC; Servatius RJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):852-60. PubMed ID: 20382195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of psychotropic agents on extinction of lever-press avoidance in a rat model of anxiety vulnerability.
    Jiao X; Beck KD; Stewart AL; Smith IM; Myers CE; Servatius RJ; Pang KC
    Front Behav Neurosci; 2014; 8():322. PubMed ID: 25309372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex-specific effects of social isolation stress and ketamine on hippocampal plasticity.
    Logue J; Schoepfer K; Guerrero AB; Zhou Y; Kabbaj M
    Neurosci Lett; 2022 Jan; 766():136301. PubMed ID: 34688854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Wistar-Kyoto rat model of depression and the role of synaptic plasticity in depression and antidepressant response.
    Aleksandrova LR; Wang YT; Phillips AG
    Neurosci Biobehav Rev; 2019 Oct; 105():1-23. PubMed ID: 31336112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoring mood balance in depression: ketamine reverses deficit in dopamine-dependent synaptic plasticity.
    Belujon P; Grace AA
    Biol Psychiatry; 2014 Dec; 76(12):927-36. PubMed ID: 24931705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial Predictability in Avoidance Acquisition and Expression of Wistar-Kyoto and Sprague-Dawley Rats: Implications for Anxiety Vulnerability in Uncertain Situations.
    Miller DP; Allen MT; Servatius RJ
    Front Psychiatry; 2020; 11():848. PubMed ID: 32973587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing learned associations between conditioned cocaine reward and environmental stimuli in the Wistar Kyoto rat.
    Dennis TS; Beck KD; Bobzean SA; Dougall AL; Perrotti LI
    Pharmacol Biochem Behav; 2012 Nov; 103(1):76-82. PubMed ID: 22922075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hippocampal-Dependent Antidepressant Action of the H3 Receptor Antagonist Clobenpropit in a Rat Model of Depression.
    Femenía T; Magara S; DuPont CM; Lindskog M
    Int J Neuropsychopharmacol; 2015 Mar; 18(9):. PubMed ID: 25762718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamate-stimulated release of norepinephrine in hippocampal slices of animal models of attention-deficit/hyperactivity disorder (spontaneously hypertensive rat) and depression/anxiety-like behaviours (Wistar-Kyoto rat).
    Howells FM; Russell VA
    Brain Res; 2008 Mar; 1200():107-15. PubMed ID: 18295191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ketamine supresses REM sleep and markedly increases EEG gamma oscillations in the Wistar Kyoto rat model of treatment-resistant depression.
    Kantor S; Lanigan M; Giggins L; Lione L; Magomedova L; de Lannoy I; Upton N; Duxon M
    Behav Brain Res; 2023 Jul; 449():114473. PubMed ID: 37146722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.